Compare
AbbVie vs Fortrea (ABBV vs FTRE)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year AbbVie (ABBV) returned +34.4% and Fortrea (FTRE) +83.8%; so far this year the figures are +27.5% and +27.3%.
AbbVie is the larger company by market value, about 242.9 times the size of Fortrea.
Revenue grew +10.7% at ABBV and -3.4% at FTRE over the last year.
ABBV yields 2.38%. FTRE pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABBV | FTRE | |
|---|---|---|
| Price | $291.31 | $21.96 |
| 1-day | +1.07% | +7.33% |
| YTD | +27.49% | +27.30% |
| 1 year | +34.39% | +83.77% |
| 3 years | +104.47% | -22.29% |
| Market cap | $514.9B | $2.1B |
| P/E | 50.1 | — |
| P/S | 7.80 | 0.79 |
| P/B | — | 3.98 |
| Revenue growth | +10.70% | -3.40% |
| EPS growth | +340.20% | — |
| Gross margin % | 73.7 | 20.0 |
| Net margin % | 15.7 | -2.6 |
| ROE % | — | -12.9 |
| Debt / equity | — | 1.98 |
| FCF yield % | 3.7 | 8.0 |
| Dividend yield % | 2.38 | — |
| Beta | -0.03 | 1.79 |
| RSI (14) | 59.7 | 51.5 |
| Technical rating |